1. Home
  2. EDSA vs SGLY Comparison

EDSA vs SGLY Comparison

Compare EDSA & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SGLY
  • Stock Information
  • Founded
  • EDSA 2015
  • SGLY 2001
  • Country
  • EDSA Canada
  • SGLY United States
  • Employees
  • EDSA N/A
  • SGLY N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • EDSA Health Care
  • SGLY
  • Exchange
  • EDSA Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • EDSA 13.8M
  • SGLY 3.9M
  • IPO Year
  • EDSA N/A
  • SGLY 2008
  • Fundamental
  • Price
  • EDSA $2.09
  • SGLY $1.05
  • Analyst Decision
  • EDSA Strong Buy
  • SGLY
  • Analyst Count
  • EDSA 2
  • SGLY 0
  • Target Price
  • EDSA $13.00
  • SGLY N/A
  • AVG Volume (30 Days)
  • EDSA 13.1K
  • SGLY 48.3K
  • Earning Date
  • EDSA 08-08-2025
  • SGLY 08-26-2025
  • Dividend Yield
  • EDSA N/A
  • SGLY N/A
  • EPS Growth
  • EDSA N/A
  • SGLY N/A
  • EPS
  • EDSA N/A
  • SGLY N/A
  • Revenue
  • EDSA N/A
  • SGLY $2,172,036.00
  • Revenue This Year
  • EDSA N/A
  • SGLY N/A
  • Revenue Next Year
  • EDSA N/A
  • SGLY N/A
  • P/E Ratio
  • EDSA N/A
  • SGLY N/A
  • Revenue Growth
  • EDSA N/A
  • SGLY N/A
  • 52 Week Low
  • EDSA $1.55
  • SGLY $0.54
  • 52 Week High
  • EDSA $5.59
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.09
  • SGLY 53.72
  • Support Level
  • EDSA $2.03
  • SGLY $0.93
  • Resistance Level
  • EDSA $2.11
  • SGLY $1.15
  • Average True Range (ATR)
  • EDSA 0.10
  • SGLY 0.08
  • MACD
  • EDSA 0.01
  • SGLY -0.01
  • Stochastic Oscillator
  • EDSA 73.33
  • SGLY 54.55

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: